ClinicalTrials.gg
RecruitingNCT07453641Updated Mar 17, 2026

White Noise and Crying Duration After Invasive Procedures in Infants

An interventional study of White Noise Audio in White Noise, sponsored by Başakşehir Çam & Sakura City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 1 Month to 3 Months. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by Başakşehir Çam & Sakura City Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Randomized
Ages
1 Month to 3 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Crying with a site in Turkey — 2 open to participants now, 4 under way, none of them phase 3. Crying · Turkey.

Planned enrollment
10th of 11
37 · median 90
Started
2026
with 2 others
No phase
11 of 12
2 open now
Registered
10th of 12
by date
Lead sponsor
1 of 12
Başakşehir Çam & Sakura City Hospital

Among the 12 studies in Crying with a site in Turkey, this one is the 10th largest by planned enrollment of the 11 interventional ones that give a count, is one of 3 that started in 2026, is one of 11 with no phase, and was the 10th registered.

Crying

39 studies on the registry are indexed under Crying; 8 are open to participants now.

Browse Crying studies →

Open to participants now

2 of the 12 studies in Crying with a site in Turkey are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 3 Crying studies recruiting now, none set no upper age limit and 3 stop at 75 or younger; 3 take children under 18; 2 take healthy volunteers.

This study: 1 Month to 3 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Crying with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the effect of white noise applied during invasive procedures (blood sampling or intravenous access) on pain and physical parameters in infants aged 1-3 months.

Read the detailed description

White noise is a monotonous sound that mimics the intrauterine environment, protecting the baby from environmental noise and having a calming effect. The findings may demonstrate the effectiveness of white noise among non-pharmacological approaches to pain management in infants and may offer healthcare professionals an applicable intervention method. If the pain and stress-reducing effects of white noise are proven, its use in routine care could be expanded. There are no known side effects associated with white noise application. There is no risk beyond that of a normal blood draw during the procedure.

03

Conditions studied

  • White Noise

Browse trials for

Keywords

  • Infant
  • White Noise
  • Invasive Procedures
  • Cry
  • Pain
04

Who can participate

Ages eligible
1 Month to 3 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants aged 1-3 months
  • Born at term (≥37 weeks gestational age)
  • Admitted to the general pediatric ward
  • Scheduled for routine invasive procedures such as venipuncture or intravenous line placement

Exclusion criteria

Exclusion Criteria:

  • Infants with congenital anomalies
  • Infants with hearing impairments
  • Infants with a history of analgesic or pain-relieving medication use prior to the invasive procedure
  • Infants requiring intensive care unit (ICU) monitoring
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
37 participants (estimated)

Study arms

  • Experimental
    White Noise Group

    Behavioral: White Noise Audio

  • No intervention
    No White Noise Group

Interventions

  • BehavioralWhite Noise Audio

    Infants undergo routine invasive procedures while continuous white noise audio is played through speakers. Crying duration is measured immediately after each procedure to evaluate the effect of white noise on procedural distress.

06

What researchers measure

Primary outcomes

  1. Crying Duration

    Time frame: Immediately after each invasive procedure (0-5 minutes)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Mar 2026, 2 months.

Of 15 interventional studies with no phase under Crying, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2026
First posted
Mar 6, 2026
StartActual
Jan 1, 2026
Primary completionActual
Mar 15, 2026
CompletionEst.
Apr 15, 2026
Last update
Mar 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07453641
Responsible party
Şeymanur Uçum (MD, Başakşehir Çam & Sakura City Hospital) — Principal investigator
First posted
Mar 6, 2026
Start date
Jan 1, 2026
Primary completion
Mar 15, 2026
Completion
Apr 15, 2026 (estimated)
Last update
Mar 17, 2026

Study contacts

Esin YILDIZ ALDEMİR, MD, PhD
Contact
aldemiresin@gmail.com
+905324859556

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion